comparative study of shatapushpa taila nasya & shatapushpa churna in artavakshya

Not yet recruiting

• Conditions: Overweight. Ayurveda Condition: Hypo-oligomenorrhea, (2) ICD-10 Condition: E282||Polycystic ovarian syndrome. Ayurveda Condition: Hypo-oligomenorrhea,

• Registration Number: CTRI/2023/07/055258
• Lead Sponsor: Dr Lalita Prajapat

Brief Summary

In the present scenario menstrual disorder is the commonest gynecological problem in females of the reproductive age group. On account of the disturbance in intake of proper diet and rest, stress, and strain with the change of lifestyle, menstrual disorders have become a very challenging problem for working women or housewives. They may involve structural or functional disturbances and are mostly associated with the complaint of infertility, psychological problems, obesity, etc.

Nowadays in modern science scanty (Hypomenorrhea) and infrequent menstruation (oligomenorrhea) are treated by hormonal therapy and long-term use of these drugs may produce many side effects.

*Artavakshaya* may be correlated with oligomenorrhea and hypomenorrhea. In the Ayurvedic classic various *Shamana* and *Shodhana* drugs are described for *Artavakshaya. Ayurvedic medicines cure Artavakshaya* by improving *agni* and remove of *Shrotorodh*a by using these potent Ayurvedic medicines. Side effects of the allopathic treatment can be avoided. Single-drug therapy can be taken easily by females during their busy schedules. Therefore, the present study is undertaken to evaluate and compare the effect of *Shatapushpa Taila Nasya* and *Shatapushpa Churna* in the management of *Artavakshaya.*

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-07-14
• Study Start: 2023-07-28

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Age group 18- 40 yrs.
• Interval between two menstrual cycles is greater than 35 days.
• (for the last 6 months approximately) The duration of menstrual flow is 2 days or less.
• .(for the last 6 months approximately) The quantity of menses is less than 20 ml.
• Poly Cystic Ovarian Disease (PCOD) with the symptom of oligomenorrhea and hypomenorrhea.

Exclusion Criteria

• Patients below the age of 18 years and above the age of 40 years.
• Positive history of venereal diseases (HIV, HBsAg, Anti HCV, VDRL, HPV, Genital herpes, etc.) Pregnant women, lactating mothers.
• Poly Cystic Ovarian Disease (PCOD) with menorrhagia.
• Patient having organic pathology of uterus & adnexa like cervical carcinoma or any malignant growth.
• Patients will not give consent to participate in the study.
• Patients using oral contraceptive pills.
• Patients who cannot attend follow-up regularly.
• Who is participating in another study.
• Women suffering from Nasal polyp, D.N.S.(Deviated nasal septum), Rhinitis.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Regular Menstrual Cycle Improvement of quality of life	Every 4weeks

Secondary Outcome Measures

Name	Time	Method
1.Interval between two cycles (intermenstrual period/Duration between two Artava darshana)	2.Amount of menstrual flow (Artava strava pramana )

Trial Locations

Locations (1)

Opd no 24. Sir Sunderlal Hospital Varanasi uttar pradesh; 🇮🇳 Varanasi, UTTAR PRADESH, India

Opd no 24. Sir Sunderlal Hospital Varanasi uttar pradesh

🇮🇳Varanasi, UTTAR PRADESH, India

Dr Lalita Prajapat

Principal investigator

8619747311

drlalita015@gmail.com